SRVEX
Price
$27.09
Change
+$0.26 (+0.97%)
Updated
Sep 11 closing price
Net Assets
395.87M
VSTSX
Price
$360.74
Change
+$3.02 (+0.84%)
Updated
Sep 11 closing price
Net Assets
2.34T
Interact to see
Advertisement

SRVEX vs VSTSX

SRVEX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
SRVEX vs. VSTSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRVEX is a StrongBuy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.34T vs. SRVEX (396M). VSTSX pays higher dividends than SRVEX: VSTSX (1.05) vs SRVEX (0.20). SRVEX was incepted earlier than VSTSX: SRVEX (37 years) vs VSTSX (10 years). SRVEX (1.05) is less costly to investors than VSTSX (0.01). SRVEX is a more actively managed with annual turnover of: 92.00 vs. VSTSX (3.00). SRVEX has a lower initial minimum investment than VSTSX: SRVEX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 14.99 vs. SRVEX (5.80). VSTSX return over 5 years is better than : 63.04 vs. SRVEX (14.18).
SRVEXVSTSXSRVEX / VSTSX
Total Expense Ratio1.050.0110,500%
Annual Report Gross Expense Ratio1.050.0110,500%
Fund Existence37 years10 years-
Gain YTD11.42011.351101%
Front Load6%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets396M2.34T0%
Annual Yield % from dividends0.201.0519%
Returns for 1 year5.8014.9939%
Returns for 3 years34.9768.8951%
Returns for 5 years14.1863.0422%
Returns for 10 years51.55245.0621%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COKE192.613.81
+2.02%
Coca-Cola Consolidated Inc
FWDI6.550.09
+1.39%
Forward Industries Inc.
SUPN41.64-0.05
-0.12%
Supernus Pharmaceuticals
CING5.02-0.15
-2.90%
Cingulate Inc
FRGT0.87-0.11
-11.22%
Freight Technologies Inc.